Ramesh Paranjape

Ramesh Paranjape

Auto-generated profile, based on publicly available information

Ramesh Paranjape

Dr. Prabhakar Kore Basic Science Research Centre, KLE Academy of Higher Education and Research, Belagavi, India

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 November 2014 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
RMRosie Mayston
Rosie Mayston
VPVikram Patel
Vikram Patel
MAMelanie Amna Abas
Melanie Amna Abas
PKPriya Korgaonkar
Priya Korgaonkar
RPRamesh Paranjape
Ramesh Paranjape
MPMartin Prince
Martin Prince
Objective: To investigate associations between background characteristics (psychosocial adversity, risk behaviours/perception of risk and HIV‐related knowledge, perceptions and beliefs) and psychological and cognitive morbidity among people coming for testing for HIV/AIDS in Goa, India.Methods: Analysis of cross‐sectional baseline data (plus HIV status) from a prospective cohort study. Participants were recruited at the time of coming for HIV testing.Results: Consistent with associations found among general population samples, among our sample of 1934 participants, we found that indicators of psychosocial adversity were associated with CMD (common mental disorder – major depression, generalised anxiety and panic disorder) among people coming for testing for HIV. Similarly, perpetration of intimate partner violence was associated with AUD (alcohol use disorder). Two STI symptoms were associated with CMD, and sex with a non‐primary partner was associated with AUD. Suboptimal knowledge about HIV transmission and prevention was associated with low cognitive test scores. In contrast with other studies, we found no evidence of any association between stigma and CMD. There was no evidence of modification of associations by HIV status.Conclusions: Among people coming for testing for HIV/AIDS in Goa, India, we found that CMD occurred in the context of social and economic stressors (violence, symptoms of STI, poor education and food insecurity) and AUD was associated with violence and risky sexual behaviour. Further research is necessary to understand the role of gender, stigma and social norms in determining the relationship between sexual and mental health. Understanding associations between these background characteristics and psychological morbidity may help inform the design of appropriate early interventions for depression among people newly diagnosed HIV/AIDS.

5 January 2024 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
AKAnil Kumar
Anil Kumar
SHSheetal Harakuni
Sheetal Harakuni
RPRamesh Paranjape
Ramesh Paranjape
AKAnil S. Korabu
Anil S. Korabu
JPJANG BAHADUR Prasad
JANG BAHADUR Prasad

24 July 2008 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
RRRavindra K. Rawal
Ravindra K. Rawal
RTRajkamal Tripathi
Rajkamal Tripathi
SKSmitha Kulkarni
Smitha Kulkarni
RPR. Paranjape
R. Paranjape
SKS. B. Katti
S. B. Katti
Erik De ClercqErik De Clercq
Erik De Clercq

28 April 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DBDisha Bhange
Disha Bhange
NPNityanand Prasad
Nityanand Prasad
SSSwati Singh
Swati Singh
HPHarshit Kumar Prajapati
Harshit Kumar Prajapati
SMShesh Prakash Maurya
Shesh Prakash Maurya
URUday Kumar Ranga
Uday Kumar Ranga
In a multicentric, observational, investigator-blinded, and longitudinal clinical study of 764 ART-naïve subjects, we identified nine different promoter-variant strains of HIV-1 subtype C (HIV-1C) emerging in the Indian population, with some of these variants being reported for the first time. Unlike several previous studies, our work here focuses on the evolving viral regulatory elements, not coding sequences. The emerging viral strains contain additional copies of the existing transcription factor binding sites (TFBS), including TCF-1α/LEF-1, RBEIII, AP-1, and NF-κB, created by sequence duplication. The additional TFBS are genetically diverse and may blur the distinction between the modulatory region of the promoter and the viral enhancer. In a follow-up analysis, we found trends, but not significant associations between any specific variant promoter and prognostic markers, probably because the emerging viral strains might not have established mono infections yet. Illumina sequencing of four clinical samples containing a co-infection indicated the domination of one strain over the other and establishing a stable ratio with the second strain at the follow-up time-points. Since a single promoter regulates viral gene expression and constitutes the master regulatory circuit with Tat, the acquisition of additional and variant copies of the TFBS may significantly impact viral latency and latent reservoir characteristics. Further studies are urgently warranted to understand how the diverse TFBS profiles of the viral promoter may modulate the characteristics of the latent reservoir, especially following the initiation of antiretroviral therapy. Significance Statement A unique conglomeration of TFBS enables the HIV-1 promoter to accomplish two diametrically opposite functions – transcriptional activation and transcriptional silencing. The various phases of viral latency -establishment, maintenance, and reversal -collectively determine the replication fitness of individual viral strains. A profound variation in the TFBS composition of the viral promoter may significantly alter the viral latency properties and the latent reservoir characteristics. Although the duplication of certain TFBS remains a quality unique to HIV-1C, the high-level genetic recombination of HIV-1 may promote the transfer of such molecular properties to the other HIV-1 subtypes. The emergence of several promoter-variant viral strains may make the task of a ‘functional cure’ more challenging in HIV-1C.

20 October 2026 in BioNanoScience
Verified
Journal Article
Closed access
PDF file
KLKrutika Lolsure
Krutika Lolsure
NBNeha Bhalerao
Neha Bhalerao
VKVijay Kumbar
Vijay Kumbar
Malleswara Rao PeramMalleswara Rao Peram
Malleswara Rao Peram
MKManjula I. Kambi
Manjula I. Kambi
RPRamesh Paranjape
Ramesh Paranjape

1 November 2026 in Pharmacological Research - Natural Products
Verified
Journal Article
Closed access
APAkanksha Patil
Akanksha Patil
VKVijay Kumbar
Vijay Kumbar
PPPriya Patil
Priya Patil
VPVaishnavi Pawashe
Vaishnavi Pawashe
SKSucheta Banerjee Kurundkar
Sucheta Banerjee Kurundkar
RPRamesh Pranjapee
Ramesh Pranjapee